Advertisement
Home 2018

Yearly Archives: 2018

Icosapent ethyl is associated with a reduced risk for ischemic events among patients with elevated triglyceride levels despite taking statins

AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides

0
Ischemic events reduced among patients with elevated triglycerides despite taking statins
For patients with takotsubo syndrome

AHA: Cardiogenic Shock Ups Mortality in Takotsubo Syndrome

0
Patients with cardiogenic shock have increased mortality in hospital, at 60 days and five years
The patient-facing PREPARE advance care planning program plus an easy-to-read advance directive significantly increases documentation of advance care planning and patient-reported engagement

Online Tool Helps Patients With Advance Care Planning

0
Program combined with easy-to-read advance directive more effective than advance directive alone
The current Ebola outbreak in Congo is the worst in the country's recorded history

Ebola Outbreak Worst in Congo’s History

0
Deaths include 163 confirmed Ebola cases, 35 probable cases
Key guidelines for recommended physical activity in Americans have been updated

AHA: Physical Activity Guidelines for Americans Updated

0
Guidelines provide information on types, amounts of exercise for different population groups
The antiviral agent fluoxetine is well tolerated but is not effective for patients with proven or presumptive enterovirus D68-associated acute flaccid myelitis

No Efficacy Signal for Fluoxetine in EV-D68 Acute Flaccid Myelitis

0
Summative limb strength score decreased from initial examination to last follow-up with fluoxetine
Omega-3 fatty acids and vitamin D do not significantly reduce major cardiovascular events or cancer incidence

AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention

0
Second study shows no significant results for vitamin D supplementation versus placebo
Treatment with dapagliflozin is noninferior to placebo for major adverse cardiovascular events among patients with type 2 diabetes with or at risk for atherosclerotic cardiovascular disease

AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM

0
Treatment resulted in lower HF hospitalization rate in patients with, without atherosclerosis
Denosumab

Denosumab Promising for TDT-Induced Osteoporosis Treatment

0
Higher percentage increase of L1 to L4 and wrist bone mineral density with DMN, reduction in pain
More than one-third of pediatric patient safety reports in 2012 to 2017 that were related to electronic health record use were attributed to usability issues

One-Third of Peds Medication Errors Due to Usability Issues

0
EHR usability issues contribute to 36 percent of med errors; 18.8 percent may have caused harm